Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum (Q38283297)

1 September 2017

Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum (English)

1 reference

1 September 2017

1 reference

1 reference

Leishmania donovani

1 reference

15

1 reference

Daniella Castanheira Bartholomeu

1 September 2017

10

Daniella Castanheira Bartholomeu

0 references

Rodrigo Corrêa-Oliveira

13

Rodrigo Correa-Oliveira

1 reference

1 September 2017

Rodolfo C. Giunchetti

Rodolfo Cordeiro Giunchetti

11

0 references

Hira L Nakhasi

14

Hira L Nakhasi

1 reference

1 September 2017

12

Lilian Lacerda Bueno

1 reference

Lívia Silva Araújo Passos

1 September 2017

6

Lívia Silva Araújo Passos

1 reference

1 September 2017

5

Daniel Menezes Souza

1 reference

1 September 2017

Natasha Delaqua Ricci

9

Natasha Delaqua Ricci

1 reference

Ludmila Zanandreis de Mendonça

1 September 2017

7

Ludmila Zanandreis de Mendonça

1 reference

1 September 2017

Jacqueline Araújo Fiuza

1

Jacqueline Araújo Fiuza

1 reference

1 September 2017

2

Sreenivas Gannavaram

1 reference

1 September 2017

Angamuthu Selvapandiyan

4

Angamuthu Selvapandiyan

1 reference

1 September 2017

Helton da Costa Santiago

3

Helton da Costa Santiago

1 reference

1 September 2017

Denise da Silveira Lemos-Giunchetti

8

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 December 2014

1 reference

1 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

1 September 2017

33

1 reference

1 September 2017

2

1 reference

1 September 2017

280-288

1 reference

Leishmaniasis worldwide and global estimates of its incidence

1 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Canine leishmaniosis in the Old and New Worlds: unveiled similarities and differences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Live attenuated Leishmania vaccines: a potential strategic alternative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Identification of highly specific and cross-reactive antigens of Leishmania species by antibodies from Leishmania (Leishmania) chagasi naturally infected dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Canine skin and conjunctival swab samples for the detection and quantification of Leishmania infantum DNA in an endemic urban area in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

In vitro cultured peripheral blood mononuclear cells from patients with chronic schistosomiasis mansoni show immunomodulation of cyclin D1,2,3 in the presence of soluble egg antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Profile of central and effector memory T cells in the progression of chronic human chagas disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Therapeutic immunization with radio-attenuated Leishmania parasites through i.m. route revealed protection against the experimental murine visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Leishmaniasis: current status of vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Leishmania vaccines: progress and problems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Cellular immunophenotypic profile in the splenic compartment during canine visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Value of two PCR methods for the diagnosis of canine visceral leishmaniasis and the detection of asymptomatic carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Transmission potential, skin inflammatory response, and parasitism of symptomatic and asymptomatic dogs with visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Evaluation of the influence of tissue parasite density on hematological and phenotypic cellular parameters of circulating leukocytes and splenocytes during ongoing canine visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.039

10.1016/J.VACCINE.2014.11.039

7 January 2021

Identifiers

DOI

1 reference

1 September 2017

1 reference